title: Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children.
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Juhee
authors.initials: J
authors.lastname: Lee
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Michelle
authors.initials: M
authors.lastname: Shuker
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
authors.forename: Terri
authors.initials: T
authors.lastname: Brown-Whitehorn
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
authors.forename: Antonella
authors.initials: A
authors.lastname: Cianferoni
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Laura
authors.initials: L
authors.lastname: Gober
authors.affiliation: Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa; Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Amanda
authors.initials: A
authors.lastname: Muir
authors.affiliation: Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa; Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Ritu
authors.initials: R
authors.lastname: Verma
authors.affiliation: Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa; Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pa.
authors.forename: Chris
authors.initials: C
authors.lastname: Liacouras
authors.affiliation: Division of Allergy-Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa. Electronic address: spergel@email.chop.edu.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Spergel
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001706:Biopsy; D019819:Budesonide / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D057765:Eosinophilic Esophagitis / Q000188:drug therapy* / Q000473:pathology; D004947:Esophagus / Q000473:pathology; D005638:Fruit; D006722:Honey; D006801:Humans; D007223:Infant; D014677:Pharmaceutical Vehicles / Q000008:administration & dosage; D013395:Sucrose / Q000008:administration & dosage / Q000031:analogs & derivatives; D013549:Sweetening Agents / Q000008:administration & dosage
chemical_list: D000893:Anti-Inflammatory Agents; D014677:Pharmaceutical Vehicles; D013549:Sweetening Agents; D019819:Budesonide; D013395:Sucrose; C026285:trichlorosucrose